| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.27 |
5e-08 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.34 |
3e-07 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
5e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-06 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
8e-06 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
1e-05 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.33 |
1e-05 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-05 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |